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Purpose of the study
The first antiretroviral therapy was introduced in Viet-
nam in 1990 and included two nucleoside reverse tran-
scriptase inhibitors (NRTIs). More recently, non-
nucleoside reverse transcriptase inhibitors (NNRTIs)
and protease inhibitors (PIs) were available, particularly
through different programmes. In this context, it is
interesting to survey the HIV drug resistance and also
to determine the main subtypes circulating in this
country.
Methods
Plasmas from 56 seropositive patients were collected
before treatment. All patients originated from the area
of Hanoi, North Vietnam. After RNA extraction using
Nuclisens® easyMag® (Biomérieux), the sequencing of the
pol region was conducted according to the ANRS
recommendations. The DNA was sequenced on both
strands with ABI Prism 3130xl and analyzed with SeqS-
cape software to determine the differences compared to
HXB2 strain: determination of resistance was done
using the ANRS rules. ClustalX and Treeview software
allowed determining the subtype of each strain.
Summary of results
Among the 56 patients, two revealed HIV resistance to
the main NRTIs and NNRTIs (mutations Y181C and
Q151M for one patient, and G190A, Q151M, Y115FY
and K65R for the other). No resistance was observed for
the PIs, except for tipranavir; almost all strains exhibited
the association of M36I, H69K and L89M mutations.
Concerning the integrase inhibitors, two patients (differ-
ent from those exhibiting resistance for NRTIs and
NNRTIs) revealed the mutation E157Q conferring a
resistance to raltegravir. All the strains but one belonged
to the subtype CRF15_01B; the last one exhibited a
CRF08_BC subtype. Numerous polymorphic mutations
were observed among these strains.
Conclusions
In this study, 2/56 (3, 6%) patients exhibited a resistance
to the main NRTIs and NNRTIs before administration
of treatment. The same percentage of patients had
strains resistant to the raltegravir. The CRF15_01B is
the subtype the most prevalent in the population
studied.
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